| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
ACG 2021
|
Pinion, Sheila
|
|
|
7 |
1 |
p. 14
|
artikel
|
| 2 |
A whole-food exclusion diet as monotherapy for Crohn's disease
|
Sasson, Alexa N
|
|
|
7 |
1 |
p. 6-7
|
artikel
|
| 3 |
Closing toilets: more than a public inconvenience
|
The Lancet Gastroenterology & Hepatology,
|
|
|
7 |
1 |
p. 1
|
artikel
|
| 4 |
Colorectal cancer incidence, mortality, tumour characteristics, and treatment before and after introduction of the faecal immunochemical testing-based screening programme in the Netherlands: a population-based study
|
Breekveldt, Emilie C H
|
|
|
7 |
1 |
p. 60-68
|
artikel
|
| 5 |
Correction to Lancet Gastroenterol Hepatol 2021; 6: 526–27
|
|
|
|
7 |
1 |
p. e1
|
artikel
|
| 6 |
Etrolizumab for maintenance therapy in patients with moderately to severely active ulcerative colitis (LAUREL): a randomised, placebo-controlled, double-blind, phase 3 study
|
Vermeire, Severine
|
|
|
7 |
1 |
p. 28-37
|
artikel
|
| 7 |
Etrolizumab for ulcerative colitis: beyond what meets the eye
|
Agrawal, Manasi
|
|
|
7 |
1 |
p. 2-4
|
artikel
|
| 8 |
Etrolizumab versus adalimumab or placebo as induction therapy for moderately to severely active ulcerative colitis (HIBISCUS): two phase 3 randomised, controlled trials
|
Rubin, David T
|
|
|
7 |
1 |
p. 17-27
|
artikel
|
| 9 |
Harm reduction and viral hepatitis in the Philippines
|
Burki, Talha Khan
|
|
|
7 |
1 |
p. 16
|
artikel
|
| 10 |
Immune checkpoint inhibitors in colorectal cancer: dream and reality
|
André, Thierry
|
|
|
7 |
1 |
p. 4-6
|
artikel
|
| 11 |
Improving liver cancer care across Europe
|
The Lancet Gastroenterology & Hepatology,
|
|
|
7 |
1 |
p. 1
|
artikel
|
| 12 |
Inflammatory bowel disease in Lebanon: a plea for help
|
Mourad, Fadi H
|
|
|
7 |
1 |
p. 13
|
artikel
|
| 13 |
Interim evaluation of the colorectal cancer screening programme in the Netherlands
|
Hoffmeister, Michael
|
|
|
7 |
1 |
p. 8-9
|
artikel
|
| 14 |
Neoadjuvant PD-1 blockade with toripalimab, with or without celecoxib, in mismatch repair-deficient or microsatellite instability-high, locally advanced, colorectal cancer (PICC): a single-centre, parallel-group, non-comparative, randomised, phase 2 trial
|
Hu, Huabin
|
|
|
7 |
1 |
p. 38-48
|
artikel
|
| 15 |
Sustainability in gastrointestinal endoscopy
|
Baddeley, Robin
|
|
|
7 |
1 |
p. 9-12
|
artikel
|
| 16 |
The Crohn's disease exclusion diet for induction and maintenance of remission in adults with mild-to-moderate Crohn's disease (CDED-AD): an open-label, pilot, randomised trial
|
Yanai, Henit
|
|
|
7 |
1 |
p. 49-59
|
artikel
|
| 17 |
The Liver Meeting Digital Experience 2021
|
Thomas, Hugh
|
|
|
7 |
1 |
p. 15
|
artikel
|
| 18 |
Treatment of pouchitis, Crohn's disease, cuffitis, and other inflammatory disorders of the pouch: consensus guidelines from the International Ileal Pouch Consortium
|
Shen, Bo
|
|
|
7 |
1 |
p. 69-95
|
artikel
|
| 19 |
Update on the mesentery: structure, function, and role in disease
|
Coffey, J Calvin
|
|
|
7 |
1 |
p. 96-106
|
artikel
|
Tijdschrift beschrijving